• Home
  • Blog
  • Newsroom
  • Publications
  • Jobs
  • Get involved
  • Contact us
Search main website

PATHPATH

Driving transformative innovation to save lives

  • Who we are
  • What we do
  • Where we work
  • Resources
About giving »
Donate now »

Publications : Browse

Browse PATH publications

Filter browse results

Total results with these characteristics: 134

Subject: Emerging and epidemic diseases > Malaria

Page 3 of 7
  • <
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • >
Making Malaria History Website

This website features updates on the latest malaria research and news, resources for advocates and technical partners, evidence and progress from the global malaria community, and field tools currently being used by countries at the forefront of the fight against the disease.

Publication date: 2017

Region: Africa

Part of series: Websites

Malaria Control and Evaluation Partnership in Africa Global Program Website

This website about PATH’s Malaria Control and Evaluation Partnership in Africa (MACEPA) global program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2017

Region: Global

Part of series: Program websites

Malaria Vaccine Initiative Website

Launched in 2002, this website provides information on the Malaria Vaccine Initiative at PATH.

Publication date: 2017

Region: Global

Part of series: Websites

Tanzania Country Program Website

This website about PATH’s Tanzania country program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2017

Region: Africa

Part of series: Program websites

Zambia Country Program Website

This website about PATH’s Zambia country program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2017

Region: Africa

Part of series: Program websites

Adverse Event Reporting From Malaria Mass Drug Administration Rounds Conducted in Southern Province, Zambia

This poster demonstrates that the use of DHAp for malaria treatment was generally safe and well tolerated. A total of 687 adverse events (AEs) were reported (0.13% of participants, 0.24% of treatments). Four AEs were initially reported as serious adverse events, though three were later identified as not related to drug ingestion.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

The “Dynamic Epidemiology” of Malaria Elimination in El Salvador: the Role of Program Decentralization, Stratification, and Timely Treatment in the Rapid and Durable Decline in Malaria Incidence Since the Early 1980s

This poster describes the key factors that led to El Salvador’s divergence from the malaria trajectory of its neighbors—Guatemala and Honduras—in the 1980s.

Publication date: November 2016

Region: Latin America

Part of series: ASTMH posters

Case Investigation With Reactive Focal Drug Administration for Malaria in Northern Senegal

The objective of the study was to evaluate whether case investigation with focal testing and focal drug administration can decrease malaria incidence. The lack of impact attributable to the program may have been due to the large increase in cases and subsequent imperfect case investigation, with 33% of eligible cases not investigated.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

Comparing Data From a Malaria Routine Surveillance System to Health Facility Source Records in Ethiopia and Senegal

This poster, which focuses on data from Ethiopia and Senegal, shows that differences between DHIS2 and the facility source records are small and decreased from 2013 to 2014, suggesting that the system can provide accurate and timely information on malaria transmission intensity at the health-post level.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

Cost-Effectiveness of Malaria Control Measures: A Cluster-Randomized Control Trial of IRS and LLINs in Mozambique

This poster details a study evaluating the cost-effectiveness of indoor residual spraying (IRS) with pirimiphos-methyl, in addition to long-lasting insecticide-treated bednets (LLINs) in an area of high malaria transmission and emerging pyrethroid resistance.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

Do Dashboards Matter for Malaria Elimination?: Documented Experience From the Development and Testing of Visualizations, Dashboards, and Alerts for Malaria Elimination in Southern Province, Zambia

Real-time, accurate, and actionable data are critical for malaria elimination; using dashboards to visualize malaria data in Zambia is one possible solution to strengthen feedback loops to the most granular levels and motivate end users. To make dashboards matter, dashboards should be developed jointly with eventual end users and focus on tools for practical decision-making.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

Outdoor Biting Behaviour and Insecticide Resistance in Malaria Vectors Might Challenge Malaria Elimination in Southern Province, Zambia

This study aimed to monitor vector behavior, species composition, and vector susceptibility to insecticides used for malaria vector control to guide the malaria elimination agenda. Outdoor biting, early biting, pyrethroid insecticide resistance, and carbamate insecticide resistance were identified and could undermine elimination efforts. Additional interventions and sustainable insecticide resistance management strategies are likely to be required.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

PET-PCR Method for Supporting Malaria Elimination Infection Identification as Part of a Field Trial in Mass Drug Administration in Southern Zambia

This study aimed to identify infections below the level of detection of the HRP2-based RDTs used to screen a cohort of individuals followed longitudinally in a randomized control trial. A negative RDT was highly predictive of a true negative, however a positive RDT was only correct half the time. RDT-positive/PCR-negative samples were likely to have been recently treated and cleared of parasites.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

Reactive Case Investigation With Reactive Focal Testing and Treatment for Malaria in Targeted Regions in Senegal: Operational Learnings

This analysis assessed operational aspects of implementing reactive case investigation in very low malaria transmission areas in northern Senegal. Malaria incidence increased throughout the country, overwhelming the health system and contributing to case investigation not being conducted according to protocol, missing many households.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

Results From the 2015 Ethiopia National Malaria Indicator Survey

The most recent Ethiopia National Malaria Indicator Survey was conducted in 2015 and sought to measure progress toward achieving the goals and objectives of the Ethiopia National Malaria Strategic Plan 2011–2015. The survey noted improvements in intervention coverage and use, but also identified gaps in utilization of interventions, especially in low transmission areas.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

Surveillance Systems for Elimination: Lessons From Rapid Reporting Across Four Countries

Findings suggest that the selection of open source platforms such as DHIS2 and ODK and the training and mentoring of local staff at all levels can lead to a well-supported system that can produce high-quality information for decision-making.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

Targeted Community Sensitization to Reduce Anticipated Refusals in a Malaria Mass Drug Administration Trial: Lessons Learned in Southern Zambia

Participating communities were reached with information about mass drug administration (MDA) through village meetings, drama groups, radio ads, and engagement of village chiefs and local headmen among other methods. Communities that received sensitization were able to recall MDA messages, refusal rate was low (2%), and most participants reported that they believed the benefits of participating to outweigh the risks.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

Transitioning an Evidence-Based Malaria Mass Drug Administration Research Strategy to Program/Routine Mode: Factors for Consideration

Following the implementation of a successful study trial to evaluate mass drug administration (MDA), the next logical step is to transition to program mode. A modified MDA program has been developed based on evidence generated from the trial that is currently being implemented in southern Zambia.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

Using Outreach Training and Supportive Supervision to Monitor Adherence to Updated Malaria Case Management Guidelines in the Eastern Region of Ghana

To facilitate uptake of the updated national health facility guidelines and enhance the quality of malaria case management, MalariaCare supported Ghana’s National Malaria Control Program to conduct on-site training and supportive supervision (OTSS) visits to 26 districts in Ghana’s Eastern region. This poster details the results of these visits and the study’s implications for malaria case management.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

Zambia National Malaria Indicator Survey 2015: Data Collection, Processing, and Results

The 2015 malaria indicator survey (MIS) reflected high ITN coverage and increased IPTp coverage. Most provinces could further expand IRS. Despite high ITN coverage, there was not a drop in malaria prevalence by microscopy.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

Page 3 of 7
  • <
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • >

Browse publications

  • All publications
  • About PATH's work
  • Emerging and epidemic diseases
  • For advocates and policymakers
  • Health technologies
  • Maternal and child health
  • Reproductive health
  • Vaccines and immunization

Search publications

Publications by type

  • Publications by series
  • Publications by language

Publications info

  • Publications FAQ

Share this page

Get updates

Enter your email address for news and updates from PATH. Also, see the topic-specific newsletters we offer.

Connect

  • Get involved
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Pinterest
  • Google+
  • Instagram
  • Contact

About

  • Our story
  • Leadership
  • Finances
  • Where we work
  • Frequently asked questions
  • Press releases

Explore

  • PATH Blog
  • Multimedia
  • Stories
  • Publications
  • Programs and projects
  • The Vaccine Resource Library
  • Jobs

Donate

  • Donate now
  • Why give?
  • Planned giving
  • Good stewardship
Charity Navigator logo with additional label, ‘13 years at four stars!’
  • Home
  • Current RFPs
  • Privacy policy
  • Copyright policy
  • Terms of use

© 1995–2018, PATH

PATH

PATH Home

About PATH

  • About us
  • Four decades of innovation
  • The birth of PATH
  • Finances
  • FAQs

Leadership

  • Executive leaders
  • Board of directors
  • Program leaders
  • Shared services leaders

How we work

  • Corporate partnerships
  • Leadership councils
  • Global Health Innovation Hub
  • Accountability

Impact

  • Annual reports
  • Stories from the field
  • Awards and honors

Featured

Stylized treatment of the number 40.

Celebrating 40 years of innovation to save lives

Close menu

Our areas of expertise

  • Advocacy and policy
  • Applied behavioral communication
  • Devices
  • Diagnostics
  • Digital health solutions
  • Diarrheal disease and pneumonia
  • Drugs
  • Epidemic and emerging diseases
  • HIV/AIDS
  • Malaria
  • Market dynamics
  • Monitoring and evaluation
  • Neglected tropical diseases
  • Noncommunicable diseases
  • Nutrition
  • Reproductive health
  • Safe birth and newborn care
  • System and service innovations
  • Tuberculosis
  • Vaccines
  • Water, air, sanitation, and hygiene
  • Women's cancers

Featured

Man holding Sayana Press.

Sayana Press injectable contraceptive

Close menu

Global reach

  • Our global expertise
  • Belgium
  • China
  • Democratic Republic of the Congo
  • Ethiopia
  • Ghana
  • India
  • Kenya
  • Malawi
  • Mozambique
  • Myanmar
  • Peru
  • Senegal
  • South Africa
  • Switzerland
  • Tanzania
  • Uganda
  • Ukraine
  • Vietnam
  • Zambia

Featured

Illustration of a globe.

Explore our expertise around the world

Close menu

For our colleagues

  • PATH programs
  • Publications
  • Vaccine Resource Library
  • Online resources

Other resources

  • Jobs
  • Get involved
  • Newsroom
  • Contact us

Featured

Gloved hands hold a prototype of the new SD BIOLINE Onchocerciasis IgG4 rapid test.

One-stop-shop for vaccine and immunization resources

Close menu

PATH Blog

Newsroom

Jobs

About giving

Contact us